Production (Stage)
Kiora Pharmaceuticals, Inc.
KPRX
$3.08
-$0.01-0.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -529.20% | 128.73% | 143.55% | 126.45% | 123.62% |
| Total Depreciation and Amortization | 93.02% | 5.12% | -123.80% | -102.39% | -68.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -67.60% | -73.87% | -58.72% | 79.32% | 101.34% |
| Change in Net Operating Assets | 1,238.73% | 301.22% | 228.27% | -6,981.45% | 78.97% |
| Cash from Operations | -208.86% | 189.56% | 190.40% | 150.14% | 166.92% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.92% | 129.41% | 129.32% | 26.84% | 255.89% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.05% | 9.03% | -169.33% | -187.51% | -190.98% |
| Cash from Financing | -98.79% | 159.77% | 54.83% | -0.41% | 126.63% |
| Foreign Exchange rate Adjustments | -68.03% | -258.45% | 478.71% | 210.60% | 108.09% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -198.76% | 137.62% | -57.19% | -125.12% | 1,755.67% |